Next report date
Report period
Q1 2024
EPS estimate
−0.92ILS
Revenue estimate
—
−105.54 MILS
14.97 M
Om Enlivex Therapeutics Ltd.
Sektor
Bransch
VD
Oren Hershkovitz
Webbplats
Huvudkvarter
Ness Ziona
Grundat
2012
ISIN
IL0011319527
FIGI
BBG00PQNLS91
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
